AU2002210558A1 - Benzamidine derivatives comprising a sulfate group serving as ltb4 antagonists - Google Patents

Benzamidine derivatives comprising a sulfate group serving as ltb4 antagonists

Info

Publication number
AU2002210558A1
AU2002210558A1 AU2002210558A AU1055802A AU2002210558A1 AU 2002210558 A1 AU2002210558 A1 AU 2002210558A1 AU 2002210558 A AU2002210558 A AU 2002210558A AU 1055802 A AU1055802 A AU 1055802A AU 2002210558 A1 AU2002210558 A1 AU 2002210558A1
Authority
AU
Australia
Prior art keywords
sulfate group
group serving
ltb4 antagonists
benzamidine derivatives
benzamidine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002210558A
Inventor
Ralf Anderskewitz
Dr. Franz Birke
Hans Michael Jennewein
Kurt Schromm
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Boehringer Ingelheim Pharma GmbH and Co KG
Original Assignee
BOEHRINGER INGELHEIM PHARMA
Boehringer Ingelheim Pharma GmbH and Co KG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by BOEHRINGER INGELHEIM PHARMA, Boehringer Ingelheim Pharma GmbH and Co KG filed Critical BOEHRINGER INGELHEIM PHARMA
Publication of AU2002210558A1 publication Critical patent/AU2002210558A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C305/00—Esters of sulfuric acids
    • C07C305/22—Esters of sulfuric acids having oxygen atoms of sulfate groups bound to carbon atoms of six-membered aromatic rings
    • C07C305/24—Esters of sulfuric acids having oxygen atoms of sulfate groups bound to carbon atoms of six-membered aromatic rings of non-condensed six-membered aromatic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Immunology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Pulmonology (AREA)
  • Neurology (AREA)
  • Psychiatry (AREA)
  • Dermatology (AREA)
  • Hospice & Palliative Care (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Transplantation (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
AU2002210558A 2000-10-24 2001-10-19 Benzamidine derivatives comprising a sulfate group serving as ltb4 antagonists Abandoned AU2002210558A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE10052333A DE10052333A1 (en) 2000-10-24 2000-10-24 New sulfooxybenzamides
DE10052333 2000-10-24
PCT/EP2001/012127 WO2002034715A1 (en) 2000-10-24 2001-10-19 Benzamidine derivatives comprising a sulfate group serving as ltb4 antagonists

Publications (1)

Publication Number Publication Date
AU2002210558A1 true AU2002210558A1 (en) 2002-05-06

Family

ID=7660637

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2002210558A Abandoned AU2002210558A1 (en) 2000-10-24 2001-10-19 Benzamidine derivatives comprising a sulfate group serving as ltb4 antagonists

Country Status (8)

Country Link
EP (1) EP1332128A1 (en)
JP (1) JP3917516B2 (en)
AU (1) AU2002210558A1 (en)
CA (1) CA2425368C (en)
DE (1) DE10052333A1 (en)
MX (1) MXPA03003465A (en)
PE (1) PE20020542A1 (en)
WO (1) WO2002034715A1 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3983272B2 (en) * 2004-07-14 2007-09-26 有限会社 炎症研究所 Method for inhibiting tumor metastasis
EP1792623B1 (en) * 2005-07-08 2010-03-10 Leopold-Franzens-Universität Innsbruck Use of extracts and constituents of leontopodium as enhancers of cholinergic function
CN100402494C (en) * 2005-08-25 2008-07-16 江苏吴中苏药医药开发有限责任公司 Myoinositol sulfate aluminium , its preparation method and oral compositions and uses
EA024381B1 (en) 2011-03-16 2016-09-30 Криэйтив Терапьютикс Гмбх Substituted diphenyl derivatives
JP7373191B2 (en) 2017-05-12 2023-11-02 国立研究開発法人理化学研究所 Class A GPCR-binding compound variants

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU673343B2 (en) * 1992-02-05 1996-11-07 Boehringer Ingelheim International Gmbh Novel amidine derivatives, their preparation and their use as mediaments with LTB4 antagonistic effect
DE19546452A1 (en) * 1995-12-13 1997-06-19 Boehringer Ingelheim Kg New phenylamidine derivatives, process for their preparation and their use as medicaments
DE19636689A1 (en) * 1996-09-10 1998-03-12 Boehringer Ingelheim Kg New benzamidine derivatives

Also Published As

Publication number Publication date
CA2425368C (en) 2008-12-09
WO2002034715A1 (en) 2002-05-02
JP3917516B2 (en) 2007-05-23
CA2425368A1 (en) 2003-04-08
JP2004512322A (en) 2004-04-22
DE10052333A1 (en) 2002-05-02
EP1332128A1 (en) 2003-08-06
MXPA03003465A (en) 2004-12-06
PE20020542A1 (en) 2002-07-16

Similar Documents

Publication Publication Date Title
AU2001264256A1 (en) Plaster
AUPQ841300A0 (en) New aminoalcohol derivatives
AU8382901A (en) Sanitary fitting
AU2001252679A1 (en) Plaster
AU2001227535A1 (en) A core formulation
AU2002234010A1 (en) Benzamidine derivatives
AU2001227532A1 (en) A core formulation
AU2001234741A1 (en) Integrin antagonists
AU2541000A (en) Beta-phenylalanine derivatives as integrin antagonists
AUPR000900A0 (en) A berley dispenser
AUPQ643100A0 (en) A toothbrush
EP1216676B8 (en) A sanitary napkin
AU2001263850A1 (en) Pyrimidine-sulfonamides having endothelin-antagonist activity
AU4338300A (en) A second mammalian tankyrase
AU2002210558A1 (en) Benzamidine derivatives comprising a sulfate group serving as ltb4 antagonists
AU6904101A (en) Infection model
AU2548000A (en) A garment
AU2001285785A1 (en) 2-aminoalkyl-thieno[2,3-d]pyrimidines
AU5998900A (en) A valve
AU2001287962A1 (en) A ball
AUPR099200A0 (en) New formulation
AU1387801A (en) Construction machine
AU2001275913A1 (en) A sleeping chair
AU3934400A (en) A chopstick
AU2001286098A1 (en) A garment